Leading Provider of Autonomous Mobile Robots to Highlight Full End-to-End Product Movement Capabilities for Manufacturing and Industrial Applications WILMINGTON, Mass., May 22, 2023 /PRNewswire/...

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present in a fireside chat and panel as well as host one-on-one investor meetings at the Barclays Gene Editing & Therapy Summit 2023 on...

Abstracts highlight data pertaining to both Iomab-B and Actimab-A clinical results including the SIERRA Phase 3 trial, dosimetry and machine learning applications for personalized radiotherapy...

- Self-administration of etripamil in patients experiencing AFib-RVR episodes resulted in a substantial reduction in ventricular rate which was sustained over 60 minutes - Data featured in an oral...

The "Medical Device Regulations in the Middle East and North Africa Training Course" conference has been added to ResearchAndMarkets.com's offering. The size of the medical device market in the...